Switzerland· 58483002
Intelence
A etravirine product containing etravirinum, registered in Switzerland and dispensed under Swissmedic category A, on the national reimbursement list. The same ATC class is registered in 14 of our 19 countries.
Checked against BAG Spezialitätenliste (Switzerland) on
Informational only — not a medical device.
Where it is registered
Etravirine is registered in 14 of 19 countries.
Countries holding a registration under ATC J05AG04 (etravirine), each read from that country’s own register.
- This record: Switzerland, from BAG Spezialitätenliste (Switzerland)
- 9 of them publish a price we can compare per daily dose
Etravirine · ATC J05AG04
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of etravirine costs, country by country.
Normalised to the WHO defined daily dose (0.4 g), the median price runs from $7.80 in France to $15.34 in Switzerland — a ×2.0 gap.
- Switzerland: $15.34 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
Etravirine · price per daily dose (0.4 g)
USD · FX 28 Sept 2026
- CH Switzerland$15.34
- FR France$7.80
The record
At a glance
BAG Spezialitätenliste (Switzerland)- Active substance
- etravirinum
- Manufacturer
- —
- Country
- Switzerland (CH)
- ATC code
- J05AG04
- ATC class
- Etravirine
- Defined daily dose
- 0.4 g, O
- Swissmedic category
- A
- Reimbursed
- Yes
- Source register
- BAG Spezialitätenliste (Switzerland)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- gtin768058483002160 StkCHF 381.55
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
316 interactions on record for etravirine.
Graded by severity as the source publishes them — 33 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Etravirine · interactions on record
316 records
- 33 severe
- 260 moderate
- 14 minor
Most severe, free to view
- DeflazacortH02AB13severe
- BosutinibL01EA04severe
- EncorafenibL01EC03severe
- BrigatinibL01ED04severe
9 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Etravirine in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesetravirineAmneal Pharmaceuticals NY LLC
- FinlandIntelenceParanova Oy
- NorwayIntelenceJanssen-Cilag International N.V.
- FranceINTELENCE 200 mg, compriméJANSSEN CILAG INTERNATIONAL NV
- United KingdomIntelence 200mg tabletsJanssen-Cilag Ltd
- CanadaINTELENCEJANSSEN INC
- IcelandINTELENCEJanssen-Cilag International NV*
- NetherlandsIntelence 200 mg, tabletJanssen-Cilag International NV
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Intelence
- Liechtenstein · Intelence
- Norway · Intelence
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of BAG Spezialitätenliste (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/95e5333c-3427-4fe9-9a1b-7a82a4514179 GET /v1/drugs/95e5333c-3427-4fe9-9a1b-7a82a4514179?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"unit": null,
"strength": "etravirinum 200 mg",
"valid_from": "2012-02-01",
"limitations": "[{\"description\":\"Erwachsene und Kinder ab 6 Jahren, die bereits andere antiretrovirale Therapien erhalten haben, darunter auch Patienten mit Resistenz gegenüber anderen Nicht-Nukleosid reverse Transkriptasehemmern (non-nucleoside reverse transcriptase inhibitors – NNRTI) sowie bereits mit Intelence eingestellte Patienten.<br>\\n<br>\\n\",\"costApproval\":null,\"indication\":null,\"isNew\":false,\"limitationCode\":null,\"points\":null,\"priceModel\":null,\"title\":null,\"validFrom\":\"2019-12-01\",\"validTo\":null}]",
"galenic_form": "Tabl 200 mg",
"therapeutic_area": null,
"sl_inclusion_date": "2012-02-01",
"self_retention_pct": 10
}See everything about etravirine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.